Centauri Therapeutics secured a £6 million series A extension investment from the AMR Action Fund,
08 February 2026
08 February 2026
Total investments received (USD): 40.58M
Round value (USD): 8.11M
Round investors: AMR Action Fund
Company: Centauri Therapeutics
Industry: BiotechHealth services
Related deals
Brainomix in a £4.8 million Series C extension co-led by Parkwalk and Hostplus, joined by Modi Ventures.
Investments
13 February 2026
Tozaro in a £6M financing round with equity contributed by Mercia Ventures and Midlands Engine Investment Fund in the UK
Investments
06 February 2026
NuVision raises £4.8M in an equity round led by Mercia Ventures, University of Nottingham and Pioneer in the UK
Investments
06 January 2026
Cyclana Bio raised £5 million pre-seed round co-led by NFX and Eka Ventures, with participation from Cocoa VC, Wilbe, and British angel investors.
Investments
04 October 2025
Enhanc3D in a $7.7M series A extension with Business Growth Fund, Parkwalk Advisors and Bioqube Ventures
Investments
18 September 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain